New therapies offer promise for cutaneous T-cell lymphoma


Some of the continuing challenges central to the management of cutaneous T-cell lymphoma (CTCL) include improving the survival and prognosis of patients, as well as helping to make proposed treatments more affordable and accessible, says Elise A. Olsen, M.D.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.